TCL Archive FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate August 14, 1992
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
TCL Archive Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’ December 11, 1992